Brieflist

Research on Complex Generics

The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., …

Read the official page on Grants.gov ↗ Get new grants like this

Funder
Food and Drug Administration (Department of Health and Human Services)
Where
🇺🇸 United States
Status
Closes 14 Dec 2026 · 24 days left
Opened
13 Nov 2026
Funding
Up to $2.5m per award
Expected awards
1
Who can apply
See the official page
Topics
Health Agriculture & food Justice & security
Opportunity number
RFA-FD-27-001
Instrument
Cooperative agreement

About this grant

The purpose of this funding opportunity is to expand access for Americans to high-quality, safe, and effective generic medicines, and help reduce the risk of drug shortages through a more competitive and multi-sourced generic drug market in the U.S., congruent with FDA’s Public Health Pillars.

Eligibility

Only the following applicant is eligible to apply for this single source funding: The University of Maryland

Applying for grants? Grants Pro e-mails you every morning with the new grants and opened forecasts that match your saved searches, and adds deadline reminders in your calendar, a private RSS feed and CSV export. Try it free for 7 days, then $9/month, cancel any time. See what Pro does →

More from this funder: 12 open opportunities from Food and Drug Administration (FDA).

Applying? Read how to write a winning grant proposal.

Data from Grants.gov, US federal government (public domain). Last checked 19 Nov 2026. Always read the official page before applying: it has the full conditions, documents and how to apply.

Similar grants